Why your FDA predicate strategy can influence what you build

Predicate identification usually happens late — once a product is largely built and a 510(k) is being drafted.

This paper explains what a predicate actually does for a substantial equivalence argument, how predicate choice can constrain claims, testing and even technology decisions, and why investigating predicate options early changes what “done” actually requires of the finished product.